Clearside Biomedical, Inc. (CLSD) Operating Income (Loss) USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Clearside Biomedical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2024.
  • Clearside Biomedical, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$8.21 M, a 7.94% decline year-over-year.
  • Clearside Biomedical, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$25.4 M, a 15.8% increase year-over-year.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2023 was -$24.8 M, a 17.9% increase from 2022.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2022 was -$30.3 M, a 4729% decline from 2021.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2021 was -$627 K, a 96.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$25.4 M -$8.21 M -$604 K -7.94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$24.8 M -$2.92 M +$5.16 M +63.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$30 M -$7.05 M -$330 K -4.91% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$29.7 M -$7.27 M +$567 K +7.24% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$30.2 M -$7.61 M +$41 K +0.54% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$30.3 M -$8.07 M -$26.8 M -143% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$3.5 M -$6.72 M -$1.84 M -37.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.67 M -$7.84 M -$1.74 M -28.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $76 K -$7.65 M +$703 K +8.42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$627 K $18.7 M +$25.8 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 -$26.4 M -$4.89 M -$2.46 M -101% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$24 M -$6.1 M -$539 K -9.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$23.4 M -$8.35 M -$5.51 M -194% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$17.9 M -$7.11 M -$4.1 M -136% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 -$13.8 M -$2.43 M +$3.94 M +61.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$17.8 M -$5.56 M +$60 K +1.07% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$17.8 M -$2.84 M +$12.5 M +81.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$30.3 M -$3.01 M +$18.6 M +86.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 -$48.9 M -$6.37 M +$17.6 M +73.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$66.5 M -$5.62 M +$15.3 M +73.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$81.8 M -$15.3 M +$1.15 M +6.97% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$82.9 M -$21.6 M -$5.31 M -32.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 -$77.6 M -$24 M -$5.76 M -31.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$71.9 M -$20.9 M -$7.27 M -53.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$64.6 M -$16.5 M -$6.2 M -60.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$58.4 M -$16.3 M -$6.96 M -74.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-13
Q3 2017 -$51.4 M -$18.2 M -$12.9 M -243% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$38.6 M -$13.6 M -$8.46 M -163% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$30.1 M -$10.3 M -$4.9 M -91.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$25.2 M -$9.36 M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 -$5.31 M -$1.93 M -57.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$5.18 M -$8 K -0.16% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$5.36 M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 -$3.37 M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$5.17 M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.